Clinical updates, including trial initiations, enrollment status and data readouts and publications: 3Sbio, Algernon, Arcutis, Astrazeneca, Bellerophon, Bioshin, Cytodyn, Dnatrix, Eisai, Faron, Gemvax & Kael, Idorsia, IGC, Immunocore, Imugene, Innovent, Inovio, Karyopharm, Maplight, Molecular Partners, Neurana, Pfizer, PMV, Silicon Therapeutics, Saniona, Selecta, Syndevrx.